| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Are we ready to look beyond plasma cells in assessing high-risk smoldering myeloma?
|
Maclachlan, Kylee H.
|
|
|
40 |
11 |
p. 1270-1272
|
article
|
| 2 |
CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition
|
Liu, Xinwei
|
|
|
40 |
11 |
p. 1341-1357.e13
|
article
|
| 3 |
Could SIRPA expression predict response to anti-PD-1 immunotherapy?
|
Jogerst, Kristen
|
|
|
40 |
11 |
p. 1269-1270
|
article
|
| 4 |
Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells
|
Zhang, Xingying
|
|
|
40 |
11 |
p. 1407-1422.e7
|
article
|
| 5 |
FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer
|
Han, Ming
|
|
|
40 |
11 |
p. 1306-1323.e8
|
article
|
| 6 |
High-performance multiplex drug-gated CAR circuits
|
Li, Hui-Shan
|
|
|
40 |
11 |
p. 1294-1305.e4
|
article
|
| 7 |
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
|
Sklavenitis-Pistofidis, Romanos
|
|
|
40 |
11 |
p. 1358-1373.e8
|
article
|
| 8 |
KIT as a therapeutic target in neuroendocrine prostate cancer
|
Azad, Arun A.
|
|
|
40 |
11 |
p. 1266-1268
|
article
|
| 9 |
Let’s turn the CAR-T cells ON and OFF precisely
|
Zhang, Jiqin
|
|
|
40 |
11 |
p. 1264-1266
|
article
|
| 10 |
Loss of p53 and genetic evolution in pancreatic cancer: Ordered chaos after the guardian is gone
|
Wu, Bogang
|
|
|
40 |
11 |
p. 1276-1278
|
article
|
| 11 |
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
|
Li, Keyu
|
|
|
40 |
11 |
p. 1374-1391.e7
|
article
|
| 12 |
Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin
|
Foster, Deshka S.
|
|
|
40 |
11 |
p. 1392-1406.e7
|
article
|
| 13 |
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
|
Pichiorri, Flavia
|
|
|
40 |
11 |
p. 1441
|
article
|
| 14 |
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
|
Pichiorri, Flavia
|
|
|
40 |
11 |
p. 1442
|
article
|
| 15 |
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
|
Garofalo, Michela
|
|
|
40 |
11 |
p. 1440
|
article
|
| 16 |
Spatial epitope barcoding reveals clonal tumor patch behaviors
|
Rovira-Clavé, Xavier
|
|
|
40 |
11 |
p. 1423-1439.e11
|
article
|
| 17 |
Squamous cell lung cancer: Current landscape and future therapeutic options
|
Lau, Sally C.M.
|
|
|
40 |
11 |
p. 1279-1293
|
article
|
| 18 |
The therapeutic window of antibody drug conjugates: A dogma in need of revision
|
Colombo, Raffaele
|
|
|
40 |
11 |
p. 1255-1263
|
article
|
| 19 |
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
|
Zhou, Zhicheng
|
|
|
40 |
11 |
p. 1324-1340.e8
|
article
|
| 20 |
What’s in a name? An emerging framework for cancer-associated fibroblasts, myofibroblasts, and fibroblasts
|
Hasan, Shakir
|
|
|
40 |
11 |
p. 1273-1275
|
article
|
Journal description